New Whitepaper Compares Targeted Resequencing Strategies
News Jul 17, 2013
Oxford Gene Technology (OGT) has produced a new, free-to-download whitepaper titled ‘When to use targeted resequencing - Choosing the right NGS method.’
The paper aims to assist researchers when planning NGS strategies by providing a detailed review of the major resequencing methods.
Comparing and contrasting method suitability, the paper also examines the significant impact of data analysis, as well as time and cost considerations.
OGT has written the whitepaper in response to a growing demand from within its customer base and the NGS community for a balanced and comprehensive guide to targeted resequencing strategies.
Considered from both clinical research and discovery viewpoints, the paper discusses whole exome and targeted panel sequencing strategies, without bias.
This includes highlighting the limitations of each approach, and offering advice on when whole genome sequencing is appropriate, providing researchers with insight to identify the most suitable method for the task at hand.
Considerations are also presented on choice of capture technologies, bait design and the use of service providers for method optimization and accessibility to meaningful results.
Genetic Discovery Helps Determine the Difference Between Aggressive & Benign Bone TumorsNews
The first genetic marker for the bone tumor, osteoblastoma, has been discovered. Whole-genome and transcriptome sequencing of human bone tumors revealed that a genetic change that affects the transcription factor, FOS, is a hallmark mutation of osteoblastoma. The results will help clinicians correctly distinguish benign osteoblastoma tumors from aggressive osteosarcoma tumors and direct the correct treatment.READ MORE
Improved Method for Isolating Extracellular RNANews
In a breakthrough that could lead to powerful new ways to diagnose and track a wide range of medical conditions, scientists at The Rockefeller University have devised an improved method for isolating and identifying tiny fragments of RNA in human blood products.READ MORE